Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
Phase 2
- Conditions
- First Posted Date
- 2004-06-09
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- SmithKline Beecham
- Target Recruit Count
- 40
- Registration Number
- NCT00003733
- Locations
- π¬π§
Mount Vernon Hospital, Northwood, England, United Kingdom
π¬π§Charing Cross Hospital, London, England, United Kingdom
Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)
Phase 2
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- SmithKline Beecham
- Target Recruit Count
- 54
- Registration Number
- NCT00002395
- Locations
- πΊπΈ
Veteran's Administration Hosp / West LA, Los Angeles, California, United States
πΊπΈJohns Hopkins Univ, Baltimore, Maryland, United States
πΊπΈHIV Institute / Davies Med Ctr, San Francisco, California, United States
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
Phase 3
Completed
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- SmithKline Beecham
- Registration Number
- NCT00002191
- Locations
- πΊπΈ
George Washington Univ 5-403A, Washington, District of Columbia, United States
πΊπΈNew York Univ, New York, New York, United States
πΊπΈDavies Med Ctr, San Francisco, California, United States
Β© Copyright 2024. All Rights Reserved by MedPath